Applied DNA Sciences, Inc. announced the general availability of Linea?? IVT platform evaluation kits (the "Kit") and the first shipment of a Kit to an existing Linea?? IVT Template customer.

The newly launched Kit, comprised of Linea?? IV T template, a buffer system, and Linea?? RNA Polymerase (RNAP), supports the conversion of current template evaluation customers to Linea IVT.

The Linea IVT platform combines cell-free, enzymatically produced Linea?? DNA IVT templates with its proprietary Linea RNAP to deliver multiple advantages over conventional mRNA production, including: 1) the elimination of plasmid DNA as a starting material; 2) the prevention or reduction of dsRNA contamination resulting in higher target mRNA yields; and, 3) the delivery of IVT templates in as little as 14 days for milligram scale and 30 days for gram scale.